CUV clinuvel pharmaceuticals limited

News: CUV Clinuvel Pharmaceuticals Says Afamelanotide Received Positive Opinion For Orphan Drug...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    June 24 (Reuters) - Clinuvel Pharmaceuticals Ltd (CUV) :

    • DRUG AFAMELANOTIDE RECEIVED POSITIVE OPINION FOR ORPHAN DRUG DESIGNATION FROM EUROPEAN MEDICINES AGENCY

    (([email protected];))

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$11.84
Change
0.600(5.34%)
Mkt cap ! $591.9M
Open High Low Value Volume
$11.24 $12.13 $11.23 $3.118M 263.4K

Buyers (Bids)

No. Vol. Price($)
1 3971 $11.80
 

Sellers (Offers)

Price($) Vol. No.
$11.95 2000 1
View Market Depth
Last trade - 16.10pm 17/09/2025 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.